ARTIVION, INC. Business Combination, Contingent Consideration, Liability, Current
ARTIVION, INC. (AORT) had Business Combination, Contingent Consideration, Liability, Current of $25.00 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2026-08-07
- 2026-06-30: Business Combination, Contingent Consideration, Liability, Current $25.00M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability, Current $21.49M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability, Current $20.69M.
- 2025-09-30: Business Combination, Contingent Consideration, Liability, Current $18.73M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2026-06-30 | $25.00M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $21.49M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $20.69M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $18.73M 10-Q · filed 2025-11-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-18 |
| 2021-09-30 | $17.60M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $17.30M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $16.80M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $16.43M 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |